- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/08 - Antiallergic agents
Patent holdings for IPC class A61P 37/08
Total number of patents in this class: 3552
10-year publication summary
131
|
118
|
122
|
209
|
253
|
216
|
253
|
312
|
225
|
76
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Daiichi Sankyo Company, Limited | 1829 |
45 |
Société des Produits Nestlé S.A. | 9672 |
44 |
Taisho Pharmaceutical Co., Ltd. | 844 |
42 |
Regeneron Pharmaceuticals, Inc. | 3650 |
40 |
Novartis AG | 11238 |
32 |
Takeda Pharmaceutical Company Limited | 2961 |
31 |
Shionogi & Co., Ltd. | 914 |
30 |
Ono Pharmaceutical Co., Ltd. | 454 |
28 |
Astellas Pharma Inc. | 1145 |
27 |
Osaka University | 3143 |
27 |
Dainippon Sumitomo Pharma Co., Ltd. | 234 |
26 |
Kyowa Hakko Kirin Co., Ltd. | 285 |
26 |
AstraZeneca AB | 3042 |
25 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
23 |
Glaxo Group Limited | 4496 |
22 |
The Regents of the University of California | 18943 |
20 |
Japan Tobacco Inc. | 3225 |
20 |
Riken | 1669 |
19 |
Nestec S.A. | 2777 |
18 |
KYORIN Pharmaceutical Co., Ltd. | 188 |
18 |
Other owners | 2989 |